BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7985475)

  • 1. Selection of patients with monoclonal gammopathy of undetermined significance is mandatory for a reliable use of interleukin-6 and other nonspecific multiple myeloma serum markers.
    Greco C; Ameglio F; Alvino S; Cianciulli AM; Giovannelli M; Mattei F; Vitelli G; Venturo I; Lopez M; Gandolfo GM
    Acta Haematol; 1994; 92(1):1-7. PubMed ID: 7985475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta 2-microglobulin in patients with monoclonal gammopathies.
    Di Giovanni S; Valentini G; Ravazzolo E; Carducci P; Giallonardo P; Maschio C
    Int J Biol Markers; 1987; 2(3):169-72. PubMed ID: 3131451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum beta 2-microglobulin levels in multiple myeloma and monoclonal gammapathy of undetermined significance: a clinical study of 55 patients.
    Chelazzi G; Senaldi G
    Ric Clin Lab; 1986; 16(1):53-8. PubMed ID: 3090677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of serum IL-6 level in monoclonal gammopathies.
    DuVillard L; Guiguet M; Casasnovas RO; Caillot D; Monnier-Zeller V; Bernard A; Guy H; Solary E
    Br J Haematol; 1995 Feb; 89(2):243-9. PubMed ID: 7873373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neural cell adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causes.
    Ong F; Kaiser U; Seelen PJ; Hermans J; Wijermans PW; de Kieviet W; Jaques G; Kluin-Nelemans JC
    Blood; 1996 Jan; 87(2):712-6. PubMed ID: 8555495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum interleukin-2 levels in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
    Cimino G; Avvisati G; Amadori S; Di Gregorio AO; Magliocca V; Petrucci MT; Sgadari C
    Nouv Rev Fr Hematol (1978); 1989; 31(5):329-32. PubMed ID: 2587201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of soluble IL-6 receptor in multiple myeloma as indicator of disease activity.
    Papadaki H; Kyriakou D; Foudoulakis A; Markidou F; Alexandrakis M; Eliopoulos GD
    Acta Haematol; 1997; 97(4):191-5. PubMed ID: 9158660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Leleu X; Le Friec G; Facon T; Amiot L; Fauchet R; Hennache B; Coiteux V; Yakoub-Agha I; Dubucquoi S; Avet-Loiseau H; Mathiot C; Bataille R; Mary JY;
    Clin Cancer Res; 2005 Oct; 11(20):7297-303. PubMed ID: 16243800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma].
    Scudla V; Petrová P; Minarík J; Pika T; Budíková M; Bacovský J; Repovský S
    Vnitr Lek; 2010 Jun; 56(6):591-601. PubMed ID: 20681472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The comparison of serum levels of selected biomarkers in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Scudla V; Budíková M; Pika T; Bacovský J; Minarík J; Heinzová V; Langová K
    Cas Lek Cesk; 2009; 148(7):315-22. PubMed ID: 19642297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
    Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
    Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
    Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance.
    Bladé J; Filella X; Montoto S; Bosch F; Rosiñol L; Coca F; Giné E; Nadal E; Aymerich M; Rozman M; Montserrat E
    Br J Haematol; 2002 May; 117(2):387-9. PubMed ID: 11972522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
    Golombick T; Diamond TH; Manoharan A; Ramakrishna R
    Integr Cancer Ther; 2016 Jun; 15(2):183-9. PubMed ID: 27154182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance.
    Diamond T; Levy S; Smith A; Day P; Manoharan A
    Intern Med J; 2001 Jul; 31(5):272-8. PubMed ID: 11512598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system.
    Bataille R; Boccadoro M; Klein B; Durie B; Pileri A
    Blood; 1992 Aug; 80(3):733-7. PubMed ID: 1638024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma.
    Kaiser U; Oldenburg M; Jaques G; Auerbach B; Havemann K
    Ann Hematol; 1996 Sep; 73(3):121-6. PubMed ID: 8841099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous analysis of serum immunoglobulins in patients with M protein using cellulose acetate membrane isoelectric focusing.
    Iijima S; Shiba K; Kurihara Y; Kamei S; Kimura S; Kimura M; Fukumura Y; Kobayashi I
    J Clin Lab Anal; 1999; 13(4):145-50. PubMed ID: 10414593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.